Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial investigating efficacy and safety of glucosamine/chondroitin sulfate in patients with knee osteoarthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucosamine/Chondroitin Sulfate (glucosamine; chondroitin sulfate)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2023-02-08